Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children

Study Overview
=================
Brief Summary
-----------------
There is little epidemiological data in the literature on the therapeutic compliance of epileptic children. Yet it is a fundamental issue in the therapeutic education and balance of this pathology. To obtain more epidemiological precision on the observance of epileptic children and to propose, according to the factors involved, the improvement of practices (therapeutic education ..). Propose an evaluation of the quality of life of their children by a suitable self-questionnaire.

Official Title
-----------------
Observance of Anticonvulsant Treatments and Quality of Life of Epileptic Children

Conditions
-----------------
Epilepsy, Children, Only, Quality of Life, Seizures, Patient Compliance

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: • Child aged 5 to 17 Child who has received complete information on the organization of the research and who has not objected to his participation and the exploitation of his data Holder (s) of the parental authority present (s) having received the complete information on the organization of the research and not being opposed to the participation and the exploitation of the data of his child Epileptic child Follow-up at the neuro pediatric department of CHRU Nancy Exclusion Criteria: epileptic encephalopathy Multiply handicapped child

Ages Eligible for Study
-----------------
Minimum Age: 5 Years
Maximum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| epileptic children<br>Completion of questionnaire, during medical consultation, on compliance and quality of life | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Mean compliance | Mean compliance score measured by the validated Modified Morisky Medication Adherence Scales 8 for epileptic patients 11 subscale with a 5-point Likert scale. According to the scoring system for the MMAS, 8=high adherence, 6 to <8=medium adherence, and <6=low adherence. Patients who had a low or a moderate rate of adherence were considered nonadherent5. | 6 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Compliance score of the modified Modified Morisky Medication Adherence Scales 8 | distribution of responses to new items of the modified MMAS8 scale, internal structure) | 6 months | 
| quality of life of epileptic children | Quality of life score measured by the IImpact of Pediatric Epilepsy Scale An 11-item scale was created for children and/or parents' use (according to age) to evaluate the influence of epilepsy on the major aspects of their family and child's life 5 items scale with a 5 point Likert scale | 6 months | 
| syndromes | MMAS8 compliance score according to syndromes and equilibrium of epilepsy | 6 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
epilepsy, children, seizures, patient compliance, quality of life